IL1B and cancer: In Pt.3, with a shorter survival, we observed during treatment a decrease in nonclassical monocytes, which contribute to cancer immunosurveillance through NK cell recruitment and activation [44] and are the primary producers of the inflammatory cytokines IL-1β and tumor necrosis factor-α (TNF-α) [45].